The New German Amendment Proposal: Implications for Cannabinoid Companies in the German Market
The German Ministry of Health has recently proposed an amendment to the New Psychoactive Substances Act (NpSG), which aims to address the emergence of new chemical variants of psychoactive substances (NPS). This move is set to have significant implications for cannabinoid companies operating in the German market.